Enyglid

Enyglid is an oral medication containing repaglinide, used to manage blood sugar levels in adults with type 2 diabetes. This quick-acting drug helps control glucose spikes after meals.

Enyglid is primarily used to help manage blood sugar levels in adults with type 2 diabetes. It is often prescribed to control glucose spikes that occur after meals. Repaglinide, the active ingredient, works by stimulating the pancreas to release more insulin. This medication is typically used alongside diet and exercise to achieve optimal blood sugar control.

Common effects of Enyglid may include mild to moderate hypoglycemia, which can cause symptoms such as sweating, dizziness, and hunger. Some users may also experience gastrointestinal discomfort, such as nausea or diarrhea. These effects are generally temporary and may subside as the body adjusts to the medication.

Enyglid should be handled with care, especially by individuals with a history of liver or kidney problems. It is important to follow the prescribed dosage and timing to avoid potential side effects. Always consult a healthcare provider before starting or stopping this medication, particularly if you have other medical conditions or are taking other medications.

Enyglid may interact with certain medications, including other diabetes drugs, antibiotics, and antifungal agents. Alcohol consumption should be avoided while taking this medication, as it can increase the risk of hypoglycemia. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.